CA9 and neoplasm: Overall, 1-acylated indoline-5-sulfonamides represent a new scaffold of nanomolar inhibitors and suppressors of tumor-associated CA IX and CA XII that points out their potential as adjuvant and MDR-overcoming agents (Supplementary Materials).